Humira and Abdominal exploration - a phase IV clinical study of FDA data

Summary:

Abdominal exploration is reported as a side effect among people who take Humira (adalimumab), especially for people who are female, 40-49 old, have been taking the drug for 1 - 2 years also take Stelara, and have Hypersensitivity.

The phase IV clinical study analyzes which people have Abdominal exploration when taking Humira. It is created by eHealthMe based on reports of 758,421 people who have side effects when taking Humira from the FDA, and is updated regularly.

What is Humira?

Humira has active ingredients of adalimumab. It is often used in rheumatoid arthritis. eHealthMe is studying from 761,396 Humira users. Check the latest studies of Humira.

What is Abdominal exploration?

Abdominal exploration (surgery to examine the contents of the abdomen) is found to be associated with 66 drugs and 480 conditions by eHealthMe. Check the latest studies of Abdominal exploration.

On Jul, 05, 2026

758,421 people reported to have side effects when taking Humira.
Among them, 39 people (0.01%) have Abdominal exploration.

Could Humira cause Abdominal exploration?

Among these 39 people:

How long have people been on Humira when they have Abdominal exploration? *

What is the gender of people who have Abdominal exploration when taking Humira? *

female: 64.86 %
male: 35.14 %

What is the age of people who have Abdominal exploration when taking Humira? *

What are other drugs people take besides Humira? *

What are other side effects people have besides Abdominal exploration? *

Drug Hypersensitivity: 19 people, 48.72%
Drug Ineffective: 16 people, 41.03%
Nausea (feeling of having an urge to vomit): 15 people, 38.46%
Nausea And Vomiting: 13 people, 33.33%
Autoimmune Hepatitis: 12 people, 30.77%
Platelet Count Increased: 12 people, 30.77%
Gamma-Glutamyltransferase Increased: 12 people, 30.77%
Cholangitis Sclerosing (infection and obstruction of bile duct): 12 people, 30.77%
Bowel Movement Irregularity: 12 people, 30.77%
Blood Alkaline Phosphatase Increased: 12 people, 30.77%

What are the existing conditions these people have? *

Hypersensitivity: 12 people, 30.77%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 3 people, 7.69%
Thrombosis (formation of a blood clot inside a blood vessel): 2 people, 5.13%
Psoriasis (immune-mediated disease that affects the skin): 2 people, 5.13%
Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 1 person, 2.56%
High Blood Pressure: 1 person, 2.56%

* Approximation only. Some reports may have incomplete information.

Do you take Humira and have Abdominal exploration?

- Check whether Abdominal exploration is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Humira:

Humira (761,396 reports)

Browse all side effects of Humira:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Abdominal exploration:

Abdominal exploration (66 drugs)

Browse all the conditions that are associated with Abdominal exploration:

Abdominal exploration (480 conditions)

Related publications that referenced our studies

Chiriac A, Brzezinski P, Stolnicu S, Podoleanu C, Moldovan C, Molnar C, Taranu T, "Eosinophilia–A rare possible adverse reaction during anti-tumor necrosis factor-alpha therapy for psoriasis", Journal of Dermatological Treatment, 2016 Mar .
Chiriac A, Brzezinski P, Stolnicu S, Podoleanu C, Moldovan C, Molnar C, Taranu T, "Eosinophilia–A rare possible adverse reaction during anti-tumor necrosis factor-alpha therapy for psoriasis", Journal of Dermatological Treatment, 2016 Mar .

How the study uses the data?

The study uses data from the FDA. It is based on adalimumab (the active ingredients of Humira) and Humira (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.